MARKET

AZNCF

AZNCF

AstraZeneca
OTCPK
189.44
NaN%
Closed 09:30 01/16 EST
OPEN
--
PREV CLOSE
189.71
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
191.00
52 WEEK LOW
123.36
MARKET CAP
293.80B
P/E (TTM)
31.47
1D
5D
1M
3M
1Y
5Y
1D
EMA validates Type II Variation MAA for AstraZeneca, Daiichi’s Enhertu
TipRanks · 1h ago
Weekly Report: what happened at AZNCF last week (0112-0116)?
Weekly Report · 11h ago
Shore Capital Sticks to Its Buy Rating for AstraZeneca (AZN)
TipRanks · 2d ago
AstraZeneca price target raised to 11,000 GBp from 10,500 GBp at Deutsche Bank
TipRanks · 3d ago
Trump Trade: White House releases details on ‘Great Healthcare Plan’
TipRanks · 3d ago
Drugmakers concerned about legal risk with FDA review program, Reuters reports
TipRanks · 3d ago
Deutsche Bank Sticks to Their Sell Rating for AstraZeneca (AZN)
TipRanks · 3d ago
UBS Reaffirms Their Buy Rating on AstraZeneca (AZN)
TipRanks · 3d ago
More
About AZNCF
AstraZeneca PLC is a United Kingdom-based science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines. The Company operates across therapy areas, including Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); Vaccines and Immune Therapies (V&I), and Rare Disease. In the Oncology area, its key products include Tagrisso, Imfinzi, Calquence, Lynparza, and Enhertu. The key products of CVRM area include Farxiga/Forxiga, Brilinta/Brilique, Crestor, and Lokelma. In the R&I area, the key products are Symbicort, Fasenra, Breztri/Trixeo, and Tezspire. In the V&I Therapies area, the products are Beyfortus and FluMist. The products in the Rare Disease area are Ultomiris, Soliris, Strensiq, and Koselugo. It has about 191 projects in its development pipeline, including 19 new molecular entities (NMEs) in the late-stage pipeline. The Company distributes its products in over 125 countries.

Webull offers AstraZeneca plc stock information, including OTCPK: AZNCF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZNCF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZNCF stock methods without spending real money on the virtual paper trading platform.